Biotech Values

[DewDiligence]

>>I rarely read the COR board anymore due to the incessant BP partnering/Buyout talk.<<

"Incessant" is certainly the right word.

‘gfp’, in particular, ought to take a breather, IMHO. I know of no one more knowledgeable about COR’s technology, but I have almost stopped reading gfp’s posts because they are so damn repetitive.

At the right price, I could see myself taking a pretty large position in COR, but I’m not going to chase a stock where efficacy and LT safety in humans are still on the come.